CD44 and cancer: Since xenograft mice models do not fully reflect the nature of the human immune system, one major reason could be that CD44 is indeed expressed by many healthy cells, including T cells, fibroblasts and macrophages, and its targeting using CAR T cells might mediate toxicity in cancer patients.